Bill analyzes regional and state trends in the U.S. healthcare industry and is a national expert on health exchanges and Medicare. He authors National MCO Analyzers and Market Overviews in multiple regions as well as U.S. Access and Reimbursement reports focusing on autoimmune drugs and opioids.
Latest news
Clarivate Appoints Michael Easton as Chief Financial Officer
Experienced Clarivate leader brings more than 25 years of financial and operational expertise LONDON, July 29, 2026: Clarivate Plc (NYSE: CLVT) (“Clarivate” or the “Company”), a leading global provider of transformative intelligence, today…
Clarivate RiskMark Wins 2026 CODiE Award for Best AI Tool for Lawyers
Prestigious awards program recognizes innovative AI technology transforming trademark risk assessment for legal professionals London, U.K. July, 20, 2026. Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today…